Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Fate Therapeutics Inc. buy EF Hutton Acquisition Co. I

Fate Therapeutics Inc.
Start price
€5.72
01.03.23 / 50%
Target price
€9.37
01.03.24
Performance (%)
26.81%
End price
€7.25
02.03.24
Summary
This prediction ended on 02.03.24 with a price of €7.25. The BUY prediction by EF_Hutton_Acquisitio finished with a performance of 26.81%. EF_Hutton_Acquisitio has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Fate Therapeutics Inc. 1.206% 1.206% 122.926% -22.816%
iShares Core DAX® 0,88 % 5,63 % 8,48 % 63,92 %
iShares Nasdaq 100 2,39 % 1,57 % 28,41 % 91,99 %
iShares Nikkei 225® 4,27 % 2,52 % 50,98 % 83,96 %
iShares S&P 500 1,17 % 2,55 % 23,60 % 71,36 %

Comments by EF_Hutton_Acquisitio for this prediction

In the thread Fate Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 26.81%
Target price 9.368
Change
Ends at 01.03.24

Fate Therapeutics, Inc. (NASDAQ: FATE) had its "buy" rating re-affirmed by analysts at EF Hutton Acquisition Co. I. They now have a $10.00 price target on the stock.
Ratings data for FATE provided by MarketBeat

EF Hutton Acquisition Co. I 
0
Report Share
01.03.23
In the thread Trading Fate Therapeutics Inc.
Prediction Buy
Perf. (%) 26.81%
Target price 9.368
Change
Ends at 01.03.24

Die von EF_Hutton_Acquisitio gewählte maximale Laufzeit wurde überschritten

EF Hutton Acquisition Co. I 
0
Report Share
02.03.24